Cargando…

Efficacy and Safety of Sarilumab in COVID-19: A Systematic Review

BACKGROUND: It has been found that there is overactivation of immune response in patients with COVID-19. Several studies are going on to assess the role of immunomodulation. IL-6 antibodies such as tocilizumab have been found to have efficacy in the treatment of COVID-19. We aim to assess the role o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chamlagain, Rajan, Shah, Sangam, Sharma Paudel, Basanta, Dhital, Roman, Kandel, Bipin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8556127/ https://www.ncbi.nlm.nih.gov/pubmed/34721573 http://dx.doi.org/10.1155/2021/8903435

Ejemplares similares

CNS tuberculoma in patient with tetralogy of fallot: A case report
por: Chamlagain, Rajan, et al.
Publicado: (2021)

Case report of a spontaneous pneumothorax after the recovery from COVID‐19 pneumonia: A delayed complication
por: Shah, Sangam, et al.
Publicado: (2021)

Teenager with acute psychosis due to non-paraneoplastic anti-N-methyl-d-aspartate receptor encephalitis with a successful recovery: A case report
por: Chamlagain, Rajan, et al.
Publicado: (2022)

Safety and efficacy of coronavirus disease‐19 vaccines in chronic kidney disease patients under maintenance hemodialysis: A systematic review
por: Mehta, Neha, et al.
Publicado: (2022)

Pegcetacoplan in paroxysmal nocturnal hemoglobinuria: A systematic review on efficacy and safety
por: Shah, Sangam, et al.
Publicado: (2022)

Bronchopleural fistula and bilateral pneumothorax in a patient with COVID‐19
por: Shah, Sangam, et al.
Publicado: (2021)

Reactivation of herpes zoster after vaccination with an inactivated vaccine: A case report from Nepal
por: Shah, Sangam, et al.
Publicado: (2021)

Acute Lower Limb Ischemia in COVID-19 Patient with Delayed Presentation
por: Shah, Sangam, et al.
Publicado: (2021)

Multiple myeloma with plasmacytoma of the clivus bone presenting with multiple cranial nerve III, IV, and VI palsy: A diagnostic dilemma
por: Shah, Chiranjiwi Prasad, et al.
Publicado: (2023)

Clinical efficacy and safety of interleukin-6 receptor antagonists (tocilizumab and sarilumab) in patients with COVID-19: a systematic review and meta-analysis
por: Yu, Su-Yeon, et al.
Publicado: (2022)

Cytomegalovirus hemorrhagic colitis in an immunocompetent patient with COVID-19 infection: A case report
por: Mehta, Neha, et al.
Publicado: (2023)

Sarilumab Administration in COVID-19 Patients: Literature Review and Considerations
por: Marino, Andrea, et al.
Publicado: (2022)

Efficacy and secondary infection risk of tocilizumab, sarilumab and anakinra in COVID‐19 patients: A systematic review and meta‐analysis
por: Peng, Jingwen, et al.
Publicado: (2021)

Long-term safety and efficacy of sarilumab plus methotrexate on disease activity, physical function and radiographic progression: 5 years of sarilumab plus methotrexate treatment
por: Genovese, Mark C, et al.
Publicado: (2019)

Efficacy and Safety of Sarilumab in patients with COVID19 Pneumonia: A Randomized, Phase III Clinical Trial (SARTRE Study)
por: Sancho-López, Aránzazu, et al.
Publicado: (2021)

Clinical evaluation of the safety, efficacy and tolerability of sarilumab in the treatment of moderate to severe rheumatoid arthritis
por: Pelechas, Eleftherios, et al.
Publicado: (2019)

Long-term safety and efficacy of sarilumab with or without background csDMARDs in rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2023)

Stereoacuity among Undergraduate Medical and Nursing Students at a Tertiary Care Hospital: A Descriptive Cross-sectional Study
por: Adhikari, Pragati Gautam, et al.
Publicado: (2022)

Sarilumab monotherapy vs sarilumab and methotrexate combination therapy in patients with rheumatoid arthritis
por: Burmester, Gerd R, et al.
Publicado: (2021)

Use of tocilizumab and sarilumab alone or in combination with corticosteroids for covid-19: systematic review and network meta-analysis
por: Zeraatkar, Dena, et al.
Publicado: (2022)

Efficacy and Safety of Sarilumab in Hospitalized Patients With Coronavirus Disease 2019: A Randomized Clinical Trial
por: Sivapalasingam, Sumathi, et al.
Publicado: (2022)

Safety and Outcomes With Combination Therapy With Sarilumab and Baricitinib for Severe COVID-19 Respiratory Infection in Cancer Patients
por: Velez, Ana Paula, et al.
Publicado: (2023)

Cardiac Implications of COVID-19 in Deceased and Recovered Patients: A Systematic Review
por: Khanal, Rajaram, et al.
Publicado: (2022)

Two years of sarilumab in patients with rheumatoid arthritis and an inadequate response to MTX: safety, efficacy and radiographic outcomes
por: Genovese, Mark C, et al.
Publicado: (2018)

Safety and tolerability of subcutaneous sarilumab and intravenous tocilizumab in patients with rheumatoid arthritis
por: Emery, Paul, et al.
Publicado: (2019)

Retroperitoneal Fibrosis as a presentation with masked multiorgan involvement of IgG4‐related disease—demystifying the diagnosis: A case report from Nepal
por: Shah, Sangam, et al.
Publicado: (2021)

Sarilumab: Cytomegalovirus colitis: case report
Publicado: (2020)

Safety and efficacy of switching from adalimumab to sarilumab in patients with rheumatoid arthritis in the ongoing MONARCH open-label extension
por: Burmester, Gerd R, et al.
Publicado: (2019)

Baricitinib as rescue therapy in a patient with COVID-19 with no complete response to sarilumab
por: Cingolani, A., et al.
Publicado: (2020)

Late onset ST-elevation myocardial infarction (STEMI) in patient with COVID-19: A case report from Nepal
por: Mandal, Prince, et al.
Publicado: (2022)

Ileocaecal Tuberculosis Presenting with Massive Hematochezia: A Rare Clinical Manifestation
por: Mehta, Neha, et al.
Publicado: (2021)

Sarilumab: patient-reported outcomes in rheumatoid arthritis
por: Crotti, Chiara, et al.
Publicado: (2018)

Population Pharmacokinetics of Sarilumab in Patients with Rheumatoid Arthritis
por: Xu, Christine, et al.
Publicado: (2019)

Sarilumab: Perforated duodenal ulcer: case report
Publicado: (2021)

Effect of tocilizumab, sarilumab, and baricitinib on mortality among patients hospitalized for COVID-19 treated with corticosteroids: a systematic review and meta-analysis
por: Albuquerque, Arthur M., et al.
Publicado: (2023)

CT-IGFBP-4 as a Predictive Novel Biomarker of Ischemic Cardiovascular Events and Mortality: A Systematic Review
por: Bhattarai, Abhinav, et al.
Publicado: (2022)

Clinical Efficacy of Sarilumab Versus Upadacitinib Over 12 weeks: An Indirect Treatment Comparison
por: Huizinga, Thomas, et al.
Publicado: (2023)

Profile of sarilumab and its potential in the treatment of rheumatoid arthritis
por: Raimondo, Maria Gabriella, et al.
Publicado: (2017)

Indirect Treatment Comparison of the Efficacy and Safety of Sarilumab Monotherapy in Rheumatoid Arthritis Patients with Inadequate Response to Conventional Disease-Modifying Antirheumatic Drugs
por: Choy, Ernest, et al.
Publicado: (2019)

A phase 3 randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of sarilumab in patients with giant cell arteritis
por: Schmidt, Wolfgang A., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_l9euvv9ph9o9g1qfko0fpjma98